Medica SurB de CV (MEX:MEDICAB) EBIT: MXN908 Mil (TTM As of Dec. 2025)


MEX:MEDICAB Medica Sur SAB de CV MEX:MEDICAB
84 GF Score
Price MXN60.77
GF Value MXN47.66
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Medica SurB de CV EBIT?

Medica SurB de CV MEX:MEDICAB 84 EBIT is MXN908 Mil as of Dec. 2025. GuruFocus rates MEX:MEDICAB with a GF Score™ of 84/100 and a GF Value™ of MXN47.66 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Medica SurB de CV's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was MXN242 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was MXN908 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medica SurB de CV's annualized ROC % for the quarter that ended in Dec. 2025 was 17.99%. Medica SurB de CV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 40.88%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medica SurB de CV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 18.10%.


Medica SurB de CV  (MEX:MEDICAB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medica SurB de CV's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=855.196 * ( 1 - 35.38% )/( (3076.928 + 3065.189)/ 2 )
=552.6276552/3071.0585
=17.99 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4799.308 - 954.898 - ( 1585.823 - max(0, 1172.752 - 1940.234+1585.823))
=3076.928

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4776.726 - 1000.467 - ( 1547.791 - max(0, 1188.836 - 1899.906+1547.791))
=3065.189

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Medica SurB de CV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=966.232/( ( (2352.918 + max(-799.729, 0)) + (2374.791 + max(-837.044, 0)) )/ 2 )
=966.232/( ( 2352.918 + 2374.791 )/ 2 )
=966.232/2363.8545
=40.88 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(217.912 + 101.26 + 23.028) - (954.898 + 0 + 187.031)
=-799.729

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(221.387 + 100.593 + 20.27) - (1000.467 + 0 + 178.827)
=-837.044

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medica SurB de CV's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=907.836/5015.882
=18.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medica SurB de CV EBIT Related Terms


Medica SurB de CV EBIT Historical Data

* Premium members only.

The historical data trend for Medica SurB de CV's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medica SurB de CV EBIT Chart

Medica SurB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 690.28 753.53 816.89 669.73 907.83

Medica SurB de CV Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 208.81 227.46 216.49 222.33 241.56

MEX:MEDICAB vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Medica SurB de CV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medica SurB de CV EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medica SurB de CV's EV-to-EBIT falls into.


MEX:MEDICAB
84GF Score
Medica Sur SAB de CV MEX:MEDICAB
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medica SurB de CV EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN908 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN908 Mil mean?
Medica SurB de CV (MEX:MEDICAB) has a EBIT of MXN908 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medica SurB de CV.
Is Medica SurB de CV's EBIT too high?
Medica SurB de CV's current EBIT is MXN908 Mil. Overall, Medica SurB de CV has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's EBIT compare to HCA and THC?
Medica SurB de CV's EBIT of MXN908 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medica SurB de CV. Medica SurB de CV's current EBIT is MXN908 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Based on GuruFocus' analysis, Medica SurB de CV (MEX:MEDICAB) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN47.66, compared to a current price of MXN60.77 — trading 27.5% above its estimated fair value. The current EBIT is MXN908 Mil. Medica SurB de CV's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medica SurB de CV (MEX:MEDICAB), the current EBIT is MXN908 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medica SurB de CV (MEX:MEDICAB) Overvalued in 2026?

Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued. The current stock price of MXN60.77 is trading 27.5% above its estimated GF Value™ of MXN47.66. GuruFocus considers Medica SurB de CV to be Modestly Overvalued.

Key valuation signals for MEX:MEDICAB:

  • EBIT: MXN908 Mil
  • GF Value™: MXN47.66 vs. price of MXN60.77 (27.5% above fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the MEX:MEDICAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medica SurB de CV Business Description

Address Puente de Piedra 150, Col. Toriello Guerra,Tlalpan, Mexico, DF, MEX, 14050
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
84GF Score

Get the complete analysis for MEX:MEDICAB

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN60.77
Price
MXN47.66
GF Value